Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Syncom Formulation (India) Ltd. ( (IN:SYNCOMF) ) is now available.
Syncom Formulations (India) Limited has announced the successful acquisition of a commercial property, specifically the entire 3rd Floor of Trade Star on Andheri-Kurla Road, Mumbai, for a total consideration of ₹51.7 crore. This strategic acquisition, accepted by HDFC Bank Ltd., is expected to enhance the company’s operational capabilities and strengthen its market position.
More about Syncom Formulation (India) Ltd.
Syncom Formulations (India) Limited operates in the pharmaceutical industry, focusing on the production and distribution of a wide range of pharmaceutical products. The company is known for its commitment to quality and innovation in the healthcare sector.
Average Trading Volume: 202,555
Technical Sentiment Signal: Sell
Current Market Cap: 14.91B INR
For detailed information about SYNCOMF stock, go to TipRanks’ Stock Analysis page.